Dermira, Inc. announced the addition of Ian Clements, Ph.D., to the company's leadership team as vice president, investor relations. Dr. Clements brings over 20 years of industry experience to Dermira. Most recently, he led investor relations and corporate communications at Tobira Therapeutics, Inc., which was acquired by Allergan plc. Previously, he led investor relations and corporate communications at Avanir Pharmaceuticals, Inc., until its acquisition by Otsuka Pharmaceutical Co. Ltd. Dr. Clements also held positions at Sequenom, Inc., the Trout Group LLC, an investor relations agency, and Accelrys, Inc.